These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 31957000)
1. Kit activates interleukin-4 receptor and effector signal transducer and activator of transcription 6 independent of its cognate ligand in mouse mast cells. Sethumadhavan A; Mani M Immunology; 2020 Apr; 159(4):441-449. PubMed ID: 31957000 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of Kit expression by IL-4 and IL-10 in murine mast cells: role of STAT6 and phosphatidylinositol 3'-kinase. Mirmonsef P; Shelburne CP; Fitzhugh Yeatman C; Chong HJ; Ryan JJ J Immunol; 1999 Sep; 163(5):2530-9. PubMed ID: 10452990 [TBL] [Abstract][Full Text] [Related]
3. Lipid rafts are required for Kit survival and proliferation signals. Jahn T; Leifheit E; Gooch S; Sindhu S; Weinberg K Blood; 2007 Sep; 110(6):1739-47. PubMed ID: 17554062 [TBL] [Abstract][Full Text] [Related]
4. Stem cell factor and interleukin-4 induce murine bone marrow cells to develop into mast cells with connective tissue type characteristics in vitro. Karimi K; Redegeld FA; Heijdra B; Nijkamp FP Exp Hematol; 1999 Apr; 27(4):654-62. PubMed ID: 10210323 [TBL] [Abstract][Full Text] [Related]
5. Erythropoietin acts as an anti-inflammatory signal on murine mast cells. Wiedenmann T; Ehrhardt S; Cerny D; Hildebrand D; Klein S; Heeg K; Kubatzky KF Mol Immunol; 2015 May; 65(1):68-76. PubMed ID: 25645506 [TBL] [Abstract][Full Text] [Related]
7. Direct interaction between Kit and the interleukin-7 receptor. Jahn T; Sindhu S; Gooch S; Seipel P; Lavori P; Leifheit E; Weinberg K Blood; 2007 Sep; 110(6):1840-7. PubMed ID: 17554063 [TBL] [Abstract][Full Text] [Related]
8. Reassessment of interactions between hematopoietic receptors using common beta-chain and interleukin-3-specific receptor beta-chain-null cells: no evidence of functional interactions with receptors for erythropoietin, granulocyte colony-stimulating factor, or stem cell factor. Scott CL; Robb L; Papaevangeliou B; Mansfield R; Nicola NA; Begley CG Blood; 2000 Aug; 96(4):1588-90. PubMed ID: 10942411 [TBL] [Abstract][Full Text] [Related]
9. Candidate ligand for the c-kit transmembrane kinase receptor: KL, a fibroblast derived growth factor stimulates mast cells and erythroid progenitors. Nocka K; Buck J; Levi E; Besmer P EMBO J; 1990 Oct; 9(10):3287-94. PubMed ID: 1698611 [TBL] [Abstract][Full Text] [Related]
10. Interleukin 4 suppresses c-kit ligand-induced expression of cytosolic phospholipase A2 and prostaglandin endoperoxide synthase 2 and their roles in separate pathways of eicosanoid synthesis in mouse bone marrow-derived mast cells. Murakami M; Penrose JF; Urade Y; Austen KF; Arm JP Proc Natl Acad Sci U S A; 1995 Jun; 92(13):6107-11. PubMed ID: 7541141 [TBL] [Abstract][Full Text] [Related]
11. Combined stimulation with the T helper cell type 2 cytokines interleukin (IL)-4 and IL-10 induces mouse mast cell apoptosis. Yeatman CF; Jacobs-Helber SM; Mirmonsef P; Gillespie SR; Bouton LA; Collins HA; Sawyer ST; Shelburne CP; Ryan JJ J Exp Med; 2000 Oct; 192(8):1093-103. PubMed ID: 11034599 [TBL] [Abstract][Full Text] [Related]
12. Role of kit-ligand in proliferation and suppression of apoptosis in mast cells: basis for radiosensitivity of white spotting and steel mutant mice. Yee NS; Paek I; Besmer P J Exp Med; 1994 Jun; 179(6):1777-87. PubMed ID: 7515099 [TBL] [Abstract][Full Text] [Related]
13. A novel KIT-deficient mouse mast cell model for the examination of human KIT-mediated activation responses. Smrž D; Bandara G; Zhang S; Mock BA; Beaven MA; Metcalfe DD; Gilfillan AM J Immunol Methods; 2013 Apr; 390(1-2):52-62. PubMed ID: 23357051 [TBL] [Abstract][Full Text] [Related]
14. Combined signaling through interleukin-7 receptors and flt3 but not c-kit potently and selectively promotes B-cell commitment and differentiation from uncommitted murine bone marrow progenitor cells. Veiby OP; Lyman SD; Jacobsen SE Blood; 1996 Aug; 88(4):1256-65. PubMed ID: 8695843 [TBL] [Abstract][Full Text] [Related]
15. Cell cycle control of c-kit+IL-7R+ B precursor cells by two distinct signals derived from IL-7 receptor and c-kit in a fully defined medium. Yasunaga M; Wang F; Kunisada T; Nishikawa S; Nishikawa S J Exp Med; 1995 Aug; 182(2):315-23. PubMed ID: 7543134 [TBL] [Abstract][Full Text] [Related]
16. Simultaneous activation of signals through gp130, c-kit, and interleukin-3 receptor promotes a trilineage blood cell production in the absence of terminally acting lineage-specific factors. Kimura T; Sakabe H; Tanimukai S; Abe T; Urata Y; Yasukawa K; Okano A; Taga T; Sugiyama H; Kishimoto T; Sonoda Y Blood; 1997 Dec; 90(12):4767-78. PubMed ID: 9389693 [TBL] [Abstract][Full Text] [Related]
17. Direct effects of IL-4 on mast cells drive their intestinal expansion and increase susceptibility to anaphylaxis in a murine model of food allergy. Burton OT; Darling AR; Zhou JS; Noval-Rivas M; Jones TG; Gurish MF; Chatila TA; Oettgen HC Mucosal Immunol; 2013 Jul; 6(4):740-50. PubMed ID: 23149659 [TBL] [Abstract][Full Text] [Related]
18. Differential responsiveness of purified mouse c-kit+ mast cells and their progenitors to IL-3 and stem cell factor. Lantz CS; Huff TF J Immunol; 1995 Oct; 155(8):4024-9. PubMed ID: 7561112 [TBL] [Abstract][Full Text] [Related]
19. Interleukin-10 induces apoptosis in developing mast cells and macrophages. Bailey DP; Kashyap M; Bouton LA; Murray PJ; Ryan JJ J Leukoc Biol; 2006 Sep; 80(3):581-9. PubMed ID: 16829633 [TBL] [Abstract][Full Text] [Related]
20. TAK1 and IKK2, novel mediators of SCF-induced signaling and potential targets for c-Kit-driven diseases. Drube S; Weber F; Göpfert C; Loschinski R; Rothe M; Boelke F; Diamanti MA; Löhn T; Ruth J; Schütz D; Häfner N; Greten FR; Stumm R; Hartmann K; Krämer OH; Dudeck A; Kamradt T Oncotarget; 2015 Oct; 6(30):28833-50. PubMed ID: 26353931 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]